The U.S. Senate on May 24 passed a bipartisan resolution offered by U.S. Sen. Steve Daines (R-MT) designating May 2022 as Brain Tumor Awareness Month.
“Too many Montanans struggle with the terrible health implications of brain tumors, and I know firsthand the impact it has on the patient’s family,” Sen. Daines said. “I’m pleased to designate May as Brain Tumor Awareness Month for the fifth year in a row to help raise public awareness of brain tumors, including the opportunities for advances in brain tumor research and treatment.”
Sen. Daines sponsored Senate Resolution 648 on May 24 with five original cosponsors, including the lead cosponsor U.S. Sen. Edward Markey (D-MA).
“The lives of too many American families have been changed forever because of a loved one suffering with a brain tumor,” Sen. Markey said. “With the passage of this resolution, we reaffirm our commitment to these families and assure them that the search for innovative therapies for brain cancers remains a priority.”
The resolution states that more than an estimated 88,970 individuals will be diagnosed with a primary brain tumor in the United States this year, compared to an estimated 84,000 Americans who were diagnosed with a primary brain tumor in 2021. Currently, according to the text of the resolution, an estimated 700,000 people in the U.S. are living with a brain tumor.